BRAF and hepatocellular carcinoma: In HCC, RAS and RAF gene mutations are rare compared to melanoma, pancreas- and colon-cancers; less than 10% of HCC patients harbor RAS mutations, while Colombino et al. reported V600E mutation on BRAF in 23% of HCC patients from South Italy [25].